Axogen Statistics
NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
55.75-0.60 (-1.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Axogen by the numbers
Axogen has a market capitalization of $3.33 billion based on 59.73M shares outstanding. With trailing EPS of $-0.63, Axogen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.7% above its 50-day average and 35.8% above its 200-day average.
Average daily trading volume is 1.57M shares, or about $87.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AXGN valuation vs. peer median
| Metric | AXGN | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.33B | $889.19M | +274% |
| Forward P/E | 79.0 | 19.2 | +312% |
| Avg. volume | 1.57M | 408.47K | +285% |
Peer median across 8 companies: TMDX, LIVN, CNMD, CBLL, INMD, CV, ELMD, FOCL.
Valuation
- Market cap
- $3.33B
- Forward P/E
- 79.03
- Price / sales (latest FY)
- 14.79
- EPS (TTM)
- $-0.63
- Shares outstanding
- 59.73M
Price and trading
- Previous close
- 56.35
- Open
- 55.71
- Day range
- 55.03 – 56.91
- 52-week range
- 26.92 – 59.72
- 52-week change
- +107.48%
- Beta
- —
- Volume
- 875.45K
- Average volume
- 1.57M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 28, 2026
Additional statistics
- Market Cap
- 3.33B
- Forward Pe
- 79.03
- Eps
- -0.63
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 59.72
- Week52 Low
- 26.92
- Avg Volume
- 1.57M
- Shares Outstanding
- 59.73M
- Ma50
- 44.34
- Ma200
- 41.06
- Earnings Date
- Oct 28, 2026
- Pct From52w High
- -6.65%
- Pct From52w Low
- 107.10%